JP2022542918A5 - - Google Patents

Info

Publication number
JP2022542918A5
JP2022542918A5 JP2022505329A JP2022505329A JP2022542918A5 JP 2022542918 A5 JP2022542918 A5 JP 2022542918A5 JP 2022505329 A JP2022505329 A JP 2022505329A JP 2022505329 A JP2022505329 A JP 2022505329A JP 2022542918 A5 JP2022542918 A5 JP 2022542918A5
Authority
JP
Japan
Application number
JP2022505329A
Other languages
Japanese (ja)
Other versions
JP2022542918A (ja
JP7627683B2 (ja
JPWO2021014167A5 (https=
Filing date
Publication date
Priority claimed from GBGB1910664.0A external-priority patent/GB201910664D0/en
Application filed filed Critical
Publication of JP2022542918A publication Critical patent/JP2022542918A/ja
Publication of JP2022542918A5 publication Critical patent/JP2022542918A5/ja
Publication of JPWO2021014167A5 publication Critical patent/JPWO2021014167A5/ja
Application granted granted Critical
Publication of JP7627683B2 publication Critical patent/JP7627683B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022505329A 2019-07-25 2020-07-24 N-Tert-ブチル-4[[2-(5-クロロ-2-ヒドロキシ-フェニル)アセチル]アミノ]ピリジン-2-カルボキサミドの固体形態 Active JP7627683B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1910664.0A GB201910664D0 (en) 2019-07-25 2019-07-25 Novel forms of compound
GB1910664.0 2019-07-25
PCT/GB2020/051779 WO2021014167A1 (en) 2019-07-25 2020-07-24 Solid forms of n-tert-butyl-4[[2-(5-chloro-2-hydroxy-phneyl)acetyl]amino]pyridine-2-carboxamide

Publications (4)

Publication Number Publication Date
JP2022542918A JP2022542918A (ja) 2022-10-07
JP2022542918A5 true JP2022542918A5 (https=) 2023-07-28
JPWO2021014167A5 JPWO2021014167A5 (https=) 2023-07-28
JP7627683B2 JP7627683B2 (ja) 2025-02-06

Family

ID=67990591

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022505329A Active JP7627683B2 (ja) 2019-07-25 2020-07-24 N-Tert-ブチル-4[[2-(5-クロロ-2-ヒドロキシ-フェニル)アセチル]アミノ]ピリジン-2-カルボキサミドの固体形態

Country Status (19)

Country Link
US (1) US12281077B2 (https=)
EP (1) EP4003960A1 (https=)
JP (1) JP7627683B2 (https=)
KR (1) KR20220087430A (https=)
CN (1) CN114585607B (https=)
AU (1) AU2020318943A1 (https=)
BR (1) BR112022001276A2 (https=)
CA (1) CA3145285A1 (https=)
CL (1) CL2022000187A1 (https=)
CO (1) CO2022002046A2 (https=)
CR (2) CR20220079A (https=)
GB (1) GB201910664D0 (https=)
IL (1) IL290071B1 (https=)
MX (1) MX2022000891A (https=)
MY (1) MY207877A (https=)
PE (1) PE20221407A1 (https=)
PH (1) PH12022550193A1 (https=)
UA (1) UA129300C2 (https=)
WO (1) WO2021014167A1 (https=)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050176767A1 (en) * 2003-10-30 2005-08-11 Laval Chan Chun Kong Pyridine carboxamide and methods for inhibiting HIV integrase
CA2658362A1 (en) 2006-06-29 2008-01-03 Alantos Pharmaceuticals Holding, Inc. Metalloprotease inhibitors
WO2016042114A1 (en) * 2014-09-19 2016-03-24 F. Hoffmann-La Roche Ag Cxcl14 as a biomarker of hedgehog pathway activity for the diagnosis, prognosis and treatment of idiopathic pulmonary fibrosis
US11358947B2 (en) 2017-04-17 2022-06-14 The Regents Of The University Of California Substituted 2-acylamino-cycloalkylthiophene-3-carboxylic acid arylamides as inhibitors of calcium-activated chloride channel TMEM16A
GB201801355D0 (en) * 2018-01-26 2018-03-14 Enterprise Therapeutics Ltd Compounds

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
BR112023012656A2 (https=)
BR112021014123A2 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
BR112021017747A2 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR102021018859A2 (https=)
BR102021015500A2 (https=)
BR102021007058A2 (https=)
BR102020022030A2 (https=)
BR112023016292A2 (https=)
BR112023011539A2 (https=)
BR112023011610A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)
BR102021016551A2 (https=)
BR102021016375A2 (https=)